Summary
A federal appeals court reinstated a paused Oregon law meant to ensure transparency behind rising prescription drug prices after a legal challenge claimed it infringed on the property and free speech rights of pharmaceutical companies.
In a 2-1 decision on Tuesday, the 9th Circuit Court of Appeals …
Source: OregonLive.com
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
